Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
about
Cannabinoids for Tourette's SyndromeThe therapeutic potential of cannabis and cannabinoidsCannabinoids in health and diseaseThe endocannabinoid system as an emerging target of pharmacotherapyCannabis in the Treatment of Dystonia, Dyskinesias, and TicsEuropean clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatmentTreatment of Tourette syndrome with delta-9-tetrahydrocannabinol (delta 9-THC): no influence on neuropsychological performance.Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia.Canadian guidelines for the evidence-based treatment of tic disorders: pharmacotherapy.Cannabinoids reduce symptoms of Tourette's syndrome.Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.Emerging drugs in Tourette syndrome.Medical marijuana in neurology.Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene.The treatment of Tourette's syndrome: current opinions.The therapeutic potential of cannabinoids for movement disorders.Tourette's syndrome: clinical features, pathophysiology, and therapeutic approachesMarijuana Compounds: A Nonconventional Approach to Parkinson's Disease Therapy.Treatment strategies for tics in Tourette syndrome.The pharmacology of Tourette syndrome.Updates in medical and surgical therapies for Tourette syndrome.Pharmacotherapy of trichotillomania (hair pulling disorder): an updated systematic review.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia.Medical Marijuana in Pediatric Neurological Disorders.Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?Interaction between the endocannabinoid and serotonergic system in the exhibition of head twitch response in four mouse strains.The First World Congress on Tourette Syndrome and Tic Disorders: Controversies and Hot Topics in Etiology and Treatment.Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols.Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients.Does unilateral basal ganglia activity functionally influence the contralateral side? What we can learn from STN stimulation in patients with Parkinson's disease.Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: a pilot study.A Systematic Review of the Effectiveness of Medical Cannabis for Psychiatric, Movement and Neurodegenerative Disorders.Current Approaches and New Developments in the Pharmacological Management of Tourette Syndrome.Tourette syndrome and other chronic tic disorders: an update on clinical management.Lost in translation? A critical look at the role that animal models of obsessive compulsive disorder play in current drug discovery strategies.Methods of the pharmacological imaging of the cannabinoid system (PhICS) study: towards understanding the role of the brain endocannabinoid system in human cognition.Pharmacotherapies to tics: a systematic review.
P2860
Q24240148-433EB2ED-A2DB-4F07-817E-2410C2204503Q24600806-DA20A51F-113D-4AC2-A273-4293A4BE03FCQ24633884-F2A43F05-6108-46DE-BAB8-DC4D55E6BFF5Q24648473-B0C359F6-5B0B-4AFD-BCD5-335015CE6CACQ27336419-A042633A-83ED-42C7-B2C6-208636A16691Q28972478-8AB05924-AC41-4F5D-BA90-9F1EA86BCF1EQ33964368-82727F3C-643A-4A6B-9AD5-39E4A86C2BDEQ33976751-9F85A9E4-3268-4369-8FB0-93CC7BD468BCQ34259426-DCDF6DDC-6107-43DA-B669-5EACF36BF4ADQ34266671-DBAC4121-6215-4626-B5F5-3F220D8B5659Q34417710-8F71060B-75C6-4F2D-805F-C70726F2E8B7Q34423658-187CCADE-84A1-4AF7-95FD-5A74065FD3A7Q34449698-342591D7-976C-4EA6-A369-191943BC055DQ34547395-AAA67CF6-3D42-43BA-9B45-4662BD83246FQ34706905-2BD08D57-324F-44BC-8C7E-62FA3F1F964AQ35171113-254F520F-7997-4E4C-9891-DFF8B9007512Q36922128-B68CAF7D-56C4-49FD-8D42-047C6D0A302CQ37512670-9295AC86-A4C7-4C7A-97DF-472ED19FF452Q37845661-C1DC3D6F-CFBB-485F-888B-BB84501A541DQ38077699-A568CC26-71FA-4661-A42C-8A5DC795BFCBQ38215699-57C2A082-4102-4842-962D-105E2DC0EC02Q38268425-F6510D22-F90C-492B-9574-EE7E42A98AE2Q38503842-5369F152-FA5A-4022-BECD-7B022928B512Q38522769-B6290AE5-350C-4771-8CF3-70AAC4839529Q38523248-58FD3EB9-9E07-4743-87E3-60B397746120Q39388243-1554B385-BB03-4BCF-AB06-3531F41AE5BDQ41681317-EDF5134E-8502-4C7F-A327-944310032D29Q42147635-54EDBFCD-6D8B-432E-B072-5B93C8516A8DQ42345655-08BFBA06-E700-4277-A622-904D5833CFD7Q42352197-CA40F510-8466-4C90-9969-62BDB544518FQ42508832-2E976B0D-F319-46DF-A1F5-556C84F6FC73Q42601467-AF099447-6023-4878-93D6-E669D62E30FCQ47101767-746D8EF5-2B63-41A6-A8CE-EE6417B63984Q47559197-1E53CC16-A64B-4B7C-B113-E9AA682E22F6Q47926575-7D87F715-A390-4D4F-B7C0-717972DAB443Q49591645-891EBCBE-8028-463B-A793-5650F2ABB8A8Q50628834-E9BEFF5E-42D9-4EE2-96A7-C9A86EBE9A41Q55365792-0E85D4DC-348C-4B47-BB56-3C3B6D045AA0
P2860
Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Treatment of Tourette's syndro ...... a randomized crossover trial.
@ast
Treatment of Tourette's syndro ...... a randomized crossover trial.
@en
type
label
Treatment of Tourette's syndro ...... a randomized crossover trial.
@ast
Treatment of Tourette's syndro ...... a randomized crossover trial.
@en
prefLabel
Treatment of Tourette's syndro ...... a randomized crossover trial.
@ast
Treatment of Tourette's syndro ...... a randomized crossover trial.
@en
P2093
P356
P1433
P1476
Treatment of Tourette's syndro ...... a randomized crossover trial.
@en
P2093
Müller-Vahl KR
Schneider U
P356
10.1055/S-2002-25028
P577
2002-03-01T00:00:00Z